HEALTHEQUITY, INC.

(HQY)
  Report
Delayed Nasdaq  -  05/13 04:00:00 pm EDT
57.68 USD   +5.33%
05/02HEALTHEQUITY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/02HealthEquity Expands Board of Directors
AQ
05/02HealthEquity, Inc. Expands Board of Directors
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

JPMorgan Adjusts Price Target on HealthEquity to $56 From $82, Maintains Overweight Rating

12/21/2021 | 12:54pm EDT


ę MT Newswires 2021
All news about HEALTHEQUITY, INC.
05/02HEALTHEQUITY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, ..
AQ
05/02HealthEquity Expands Board of Directors
AQ
05/02HealthEquity, Inc. Expands Board of Directors
CI
04/11Wells Fargo Starts HealthEquity at Overweight With $95 Price Target
MT
04/07Guggenheim Starts HealthEquity at Buy With $89 Price Target
MT
03/31HEALTHEQUITY, INC. Management's discussion and analysis of financial condition and res..
AQ
03/31NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
03/30BTIG Upgrades HealthEquity to Buy from Neutral, Sets $85 Price Target
MT
03/29HealthEquity Named as One of The Healthiest Workplaces
AQ
03/28Jefferies Adjusts HealthEquity's Price Target to $80 From $62, Maintains Buy Rating
MT
More news
Analyst Recommendations on HEALTHEQUITY, INC.
More recommendations
Financials (USD)
Sales 2023 826 M - -
Net income 2023 -53,7 M - -
Net cash 2023 106 M - -
P/E ratio 2023 -91,3x
Yield 2023 -
Capitalization 4 866 M 4 866 M -
EV / Sales 2023 5,76x
Capi. / Sales 2024 5,38x
Nbr of Employees 3 702
Free-Float -
Chart HEALTHEQUITY, INC.
Duration : Period :
HealthEquity, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTHEQUITY, INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 57,68 $
Average target price 75,92 $
Spread / Average Target 31,6%
EPS Revisions
Managers and Directors
Jon Kessler President, Chief Executive Officer & Director
Tyson Murdock Chief Financial Officer & Executive Vice President
Robert W. Selander Non-Executive Chairman
Becky Whitehead EVP, Chief Technology & Information Officer
Ted Bloomberg Chief Operating Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
HEALTHEQUITY, INC.30.38%4 866
MICROSOFT CORPORATION-22.36%1 952 925
DASSAULT SYSTÈMES SE-27.16%51 985
ATLASSIAN CORPORATION PLC-50.46%48 022
SYNOPSYS INC.-25.10%42 254
SEA LIMITED-66.30%42 204